Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “anti-vegf”

40 pharma patents match "anti-vegf" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 40
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 40 pharmaceutical patents matching "anti-vegf" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

40 results for “anti-vegf” · 30,257 patents in full index Clear search

  1. US 11485770

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  2. US 11459374

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  3. US 11459373

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  4. US 11458107

    Abiotic anti-VEGF nanoparticle

    The Regents of the University of California · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  5. US 11440950

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  6. US 11407813

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  7. US 11306135

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  8. US 11299532

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  9. US 11286290

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  10. US 11186625

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  11. US 11180540

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  12. US 11174283

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  13. US 11098311

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  14. US 11098112

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  15. US 11053280

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  16. US 8834883

    Anti-VEGF antibodies and uses thereof

    VACCINEX, INC. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted